Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 84-86

  Wakim Ghorayeb, Saria F ^a   Keleshian, Sose H ^b   Timson, Georgina ^c   Finan, Ramzi R ^a   Najm, Pierre ^a   Irani Hakime, Noha ^a   Almawi, Wassim Y ^b,c  

^a St Georges University Hospital   (Lebanon)

^b HAIGAZIAN UNIVERSITY   (Lebanon)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Diabetes mellitus; Factor V Leiden; Single nucleotide polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

DIABETES MELLITUS, TYPE 2; DNA; FACTOR V; FEMALE; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; REFERENCE VALUES;

EID: 24344441902     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20406     Document Type: Article

References (10)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classifications of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
2. Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1. Metabolism 2002;51:471-476.
3. Sommeijer DW, Beganovic A, Schalkwijk CG, et al. More fibrosis and thrombotic complications but similar expression patterns of markers for coagulation and inflammation in symptomatic plaques from DM2 patients. J Histochem Cytochem 2004;52:1141-1149.
4. Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67.
5. Krekora K, De Lucia D, Capani F, Donati MB, Iacoviello L. Association of coagulation factor VArg506Gln mutation with non-insulin-dependent diabetes mellitus. Lancet 1996;348:1666-1667.
6. Maser RE, Miele ME, Lenhard MJ, et al. Lack of association of factor V Leiden and coronary heart disease in individuals with and without diabetes. Diabetes Care 1998;21:198-199.
7. Hart LM, Stolk RP, Dekker JM, et al. Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study. J Clin Endocrinol Metab 1999;84:1002-1006.
8. Odawara M, Yamashita K. Factor V Leiden mutation and Japanese NIDDM. Diabetologia 1997;40:1363-1364.
9. Tamim H, Finan RR, Almawi, WY. Prevalence of two thrombophilia predisposing mutations: factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost 2002;88:691-692.
10. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.